TY - JOUR
KW - Analgesics, Opioid
KW - buprenorphine
KW - Female
KW - Humans
KW - Opiate Substitution Treatment
KW - opioid-related disorders
KW - Pregnancy
KW - Pregnancy Complications
AU - L. E. Gressler
AU - D. Titus-Glover
AU - F. T. Shaya
A1 - 
AD - Department of Pharmaceutical Health Services Research, University of Maryland School of Pharmacy, Baltimore, MD 21201, USA.; Department of Pharmaceutical Health Services Research, University of Maryland School of Pharmacy, Baltimore, MD 21201, USA.; Department of Pharmaceutical Health Services Research, University of Maryland School of Pharmacy, Baltimore, MD 21201, USA. Electronic address: fshaya@rx.umaryland.edu.
BT - Lancet (London, England)
C5 - Opioids & Substance Use
CP - 10147
CY - England
IS - 10147
JF - Lancet (London, England)
M1 - Journal Article
PP - England
PY - 2018
SN - 1474-547X; 0140-6736
SP - 551
EP - 5. Epub 2018 Aug 16
EP - 
T1 - Treatment modalities for pregnant women with opioid use disorder
T2 - Lancet (London, England)
TI - Treatment modalities for pregnant women with opioid use disorder
U1 - Opioids & Substance Use
U2 - 30152383
VL - 392
VO - 1474-547X; 0140-6736
Y1 - 2018
Y2 - Aug 18
ER -